Top section
Top section
Placement 3.7 times subscribed, weeks after regulator halted unauthorised marketing of a purported public offer
Markus Meier and Thore Zimmermann promoted
IPO pipeline strong, but timetables slipping as markets await clarity on tax, growth and defence funding
More articles
More articles
More articles
-
TechnipFMC, the French-US energy technologies group, executed on Thursday night its second block sale of shares in Technip Energies, the engineering and construction subsidiary it span off in February. Despite the holiday season, the parent achieved a fractionally higher price than in the last trade and a significantly tighter discount. -
Glenmark Life Sciences, a pharmaceutical ingredients manufacturer, wrapped up a three-day bookbuild for its India IPO on Thursday. The deal, worth up to Rp15.5bn ($208.6m), was covered 15.5 times.
-
Chinese stocks were in freefall this week after Beijing tightened rules for the for-profit education sector, sparking a fresh — and severe — bout of volatility in the equities market. While the timing for new IPOs is far from ideal, there is hope yet for companies, say ECM bankers. Jonathan Breen reports.
-
HK Inno.N Corp, a South Korean pharmaceuticals company known for its popular hangover tonics, has priced its IPO at the top of the marketed range, netting W596.9bn ($520.9m).
-
After several quarters of strong performance among European investment banking businesses, there are signs that firms are satisfied with cost cutting measures and are prepared to resume investment instead.
-
Convertible bonds are expected to remain a popular financing tool for European companies once the market reopens in September, as long as the bull run in stocks continues.
Sub-sections
shared comment list
